growth/size/body
|
• double homozygous females display no significant differences from Irs1tm1Jos homozygous females with respect to growth or organ size
|
homeostasis/metabolism
|
• at 10-17-weeks, double homozygous females show no significant differences from Irs1tm1Jos homozygous females with respect to fed and fasted plasma insulin levels
|
|
• at 9-12 weeks, double mutant females and Irs1tm1Jos homozygous females show no significant differences in fed and fasted blood glucose levels; both groups display a comparable (mild) reponse when subjected to glucose tolerance tests
|
|
• at 9-12 weeks, double mutant females and Irs1tm1Jos homozygous females show a comparable (mild) reponse when subjected to insulin tolerance tests
|